182 related articles for article (PubMed ID: 18096213)
1. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice.
Naderi N; Haghparast A; Saber-Tehrani A; Rezaii N; Alizadeh AM; Khani A; Motamedi F
Pharmacol Biochem Behav; 2008 Mar; 89(1):64-75. PubMed ID: 18096213
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice.
Naderi N; Aziz Ahari F; Shafaghi B; Najarkolaei AH; Motamedi F
J Neural Transm (Vienna); 2008 Nov; 115(11):1501-11. PubMed ID: 18575801
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids and their interactions with diazepam on modulation of serum corticosterone concentration in male mice.
Saber-Tehrani A; Naderi N; Hosseini Najarkolaei A; Haghparast A; Motamedi F
Neurochem Res; 2010 Jan; 35(1):60-6. PubMed ID: 19590959
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice.
Gomes FV; Casarotto PC; Resstel LB; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):434-8. PubMed ID: 21111767
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
[TBL] [Abstract][Full Text] [Related]
6. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
[TBL] [Abstract][Full Text] [Related]
7. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
[TBL] [Abstract][Full Text] [Related]
8. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
Ho WS; Gardiner SM
Br J Pharmacol; 2009 Jan; 156(1):94-104. PubMed ID: 19133994
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro.
Lees G; Dougalis A
Brain Res; 2004 Jan; 997(1):1-14. PubMed ID: 14715144
[TBL] [Abstract][Full Text] [Related]
10. Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze.
Gobira PH; Aguiar DC; Moreira FA
Pharmacol Biochem Behav; 2013 Sep; 110():33-9. PubMed ID: 23711591
[TBL] [Abstract][Full Text] [Related]
11. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
Seillier A; Giuffrida A
Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity.
Shoshan N; Segev A; Abush H; Mizrachi Zer-Aviv T; Akirav I
Hippocampus; 2017 Oct; 27(10):1093-1109. PubMed ID: 28667676
[TBL] [Abstract][Full Text] [Related]
13. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.
Roohbakhsh A; Keshavarz S; Hasanein P; Rezvani ME; Moghaddam AH
Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):333-8. PubMed ID: 19614892
[TBL] [Abstract][Full Text] [Related]
14. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
Hartmann A; Fassini A; Scopinho A; Correa FM; Guimarães FS; Lisboa SF; Resstel LB
J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299
[TBL] [Abstract][Full Text] [Related]
15. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G
Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
[TBL] [Abstract][Full Text] [Related]
16. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test.
Zaitone SA; El-Wakeil AF; Abou-El-Ela SH
Behav Pharmacol; 2012 Aug; 23(4):417-25. PubMed ID: 22750843
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.
Umathe SN; Manna SS; Utturwar KS; Jain NS
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1191-9. PubMed ID: 19580839
[TBL] [Abstract][Full Text] [Related]
19. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test.
Lisboa SF; Resstel LB; Aguiar DC; Guimarães FS
Eur J Pharmacol; 2008 Sep; 593(1-3):73-8. PubMed ID: 18691568
[TBL] [Abstract][Full Text] [Related]
20. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
Haller J; Varga B; Ledent C; Freund TF
Behav Pharmacol; 2004 Jul; 15(4):299-304. PubMed ID: 15252281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]